scholarly journals Comparison of dose distributions in target areas and organs at risk in conformal and VMAT techniques and dose verifications with the use of thermoluminescence dosimetry

Nukleonika ◽  
2020 ◽  
Vol 65 (4) ◽  
pp. 217-222
Author(s):  
Monika Paluch-Ferszt ◽  
Beata Kozłowska ◽  
Marcin Dybek

AbstractThe aim of the present study is to compare dose distributions and their verification in target areas and organs at risk (OAR) in conformal and volumetric modulated arc therapy (VMAT) techniques. Proper verification procedures allow the removal of the major sources of errors, such as incorrect application of a planning system, its insufficient or cursory commissioning, as well as an erroneous interpretation of the obtained results. Three target areas (head and neck, chest, and pelvic) were selected and the treatment was delivered based on plans made using collapsed cone convolution and Monte Carlo algorithms with 6-MV photon beams, adopting conformal and VMAT techniques, respectively. All the plans were prepared for the anthropomorphic phantom. Dose measurements were performed with TL detectors made of LiF phosphor doped with magnesium and titanium (LiF:Mg,Ti). This paper presents the results of TL measurements and calculated doses, as well as their deviations from the treatment planning system (TPS) in the three planned target areas. It was established that the algorithms subject to analysis differ, particularly in dose calculations for highly inhomogeneous regions (OAR). Aside from the need to achieve the dose intended for the tumour, the choice of irradiation technique in teleradiotherapy should be dictated by the degree of exposure to individual critical organs during irradiation. While nothing deviated beyond the bounds of what is acceptable by international regulatory bodies in plans from TPS, clinically one must be more cautious with the OAR areas.

2020 ◽  
Vol 19 ◽  
pp. 153303382091571
Author(s):  
Yiwei Yang ◽  
Kainan Shao ◽  
Jie Zhang ◽  
Ming Chen ◽  
Yuanyuan Chen ◽  
...  

Objective: To evaluate and quantify the planning performance of automatic planning (AP) with manual planning (MP) for nasopharyngeal carcinoma in the RayStation treatment planning system (TPS). Methods: A progressive and effective design method for AP of nasopharyngeal carcinoma was realized through automated scripts in this study. A total of 30 patients with nasopharyngeal carcinoma with initial treatment was enrolled. The target coverage, conformity index (CI), homogeneity index (HI), organs at risk sparing, and the efficiency of design and execution were compared between automatic and manual volumetric modulated arc therapy (VMAT) plans. Results: The results of the 2 design methods met the clinical dose requirement. The differences in D95 between the 2 groups in PTV1 and PTV2 showed statistical significance, and the MPs are higher than APs, but the difference in absolute dose was only 0.21% and 0.16%. The results showed that the conformity index of planning target volumes (PTV1, PTV2, PTVnd and PGTVnx+rpn [PGTVnx and PGTVrpn]), homogeneity index of PGTVnx+rpn, and HI of PTVnd in APs are better than that in MPs. For organs at risk, the APs are lower than the MPs, and the difference was statistically significant ( P < .05). The manual operation time in APs was 83.21% less than that in MPs, and the computer processing time was 34.22% more. Conclusion: IronPython language designed by RayStation TPS has clinical application value in the design of automatic radiotherapy plan for nasopharyngeal carcinoma. The dose distribution of tumor target and organs at risk in the APs was similar or better than those in the MPs. The time of manual operation in the plan design showed a sharp reduction, thus significantly improving the work efficiency in clinical application.


Author(s):  
Leonie Brodbek ◽  
Jana Kretschmer ◽  
Katrin Büsing ◽  
Hui Khee Looe ◽  
Bjoern Poppe ◽  
...  

Abstract The RUBY head phantom in combination with the System QA insert MultiMet can be used for simultaneous point dose measurements at an isocentric and two off-axis positions. This study investigates the suitability of the system for systematic integral end-to-end testing of single-isocenter multiple target stereotactic treatments. Several volumetric modulated arc therapy plans were optimized on a planning CT of the phantom positioned in a stereotactic mask on the stereotactic treatment board. The plans were created for three artificial spherical target volumes centred around the measurement positions in the MultiMet insert. Target diameters between 5 and 40 mm were investigated. Coplanar and non-coplanar plans were optimized using the collapsed cone algorithm of the Oncentra Masterplan treatment planning system and recalculated with the Monte Carlo algorithm of the Monaco treatment planning system. Measurements were performed at an Elekta Synergy linear accelerator. The head phantom was positioned according to clinical workflow comprising immobilization and CBCT imaging. Simultaneous point dose measurements at all target positions were performed with three PinPoint 3D chambers (type 31022) as well as three microDiamond (type 60019) detectors and compared to the treatment planning system calculations. Furthermore, the angular dependence of the detector response was investigated to estimate the associated impact on the measured point dose values. Considering all investigated plans, PTV diameters and positions, the point doses calculated with the Monaco treatment planning system and the microDiamond measurements differed within 3.5%, whereas the PinPoint 3D showed differences of up to 6.9%. Point dose differences determined in comparison to the Oncentra Masterplan dose calculations were larger. The RUBY system was shown to be suitable for end-to-end testing of complex treatment scenarios such as single-isocenter multiple target plans.


2020 ◽  
Vol 15 (1) ◽  
Author(s):  
Wufei Cao ◽  
Yongdong Zhuang ◽  
Lixin Chen ◽  
Xiaowei Liu

Abstract Purpose In this study, we employed a gated recurrent unit (GRU)-based recurrent neural network (RNN) using dosimetric information induced by individual beam to predict the dose-volume histogram (DVH) and investigated the feasibility and usefulness of this method in biologically related models for nasopharyngeal carcinomas (NPC) treatment planning. Methods and materials One hundred patients with NPC undergoing volumetric modulated arc therapy (VMAT) between 2018 and 2019 were randomly selected for this study. All the VMAT plans were created using the Monaco treatment planning system (Elekta, Sweden) and clinically approved: > 98% of PGTVnx received the prescribed doses of 70 Gy, > 98% of PGTVnd received the prescribed doses of 66 Gy and > 98% of PCTV received 60 Gy. Of these, the data from 80 patients were used to train the GRU-RNN, and the data from the other 20 patients were used for testing. For each NPC patient, the DVHs of different organs at risk were predicted by a trained GRU-based RNN using the information given by individual conformal beams. Based on the predicted DVHs, the equivalent uniform doses (EUD) were calculated and applied as dose constraints during treatment planning optimization. The regenerated VMAT experimental plans (EPs) were evaluated by comparing them with the clinical plans (CPs). Results For the 20 test patients, the regenerated EPs guided by the GRU-RNN predictive model achieved good consistency relative to the CPs. The EPs showed better consistency in PTV dose distribution and better dose sparing for many organs at risk, and significant differences were found in the maximum/mean doses to the brainstem, brainstem PRV, spinal cord, lenses, temporal lobes, parotid glands and larynx with P-values < 0.05. On average, compared with the CPs, the maximum/mean doses to these OARs were altered by − 3.44 Gy, − 1.94 Gy, − 1.88 Gy, 0.44 Gy, 1.98 Gy, − 1.82 Gy and 2.27 Gy, respectively. In addition, significant differences were also found in brainstem and spinal cord for the dose received by 1 cc volume with 4.11 and 1.67 Gy dose reduction in EPs on average. Conclusion The GRU-RNN-based DVH prediction method was capable of accurate DVH prediction. The regenerated plans guided by the predicted EUDs were not inferior to the manual plans, had better consistency in PTVs and better dose sparing in critical OARs, indicating the usefulness and effectiveness of biologically related model in knowledge-based planning.


2019 ◽  
Vol 19 (4) ◽  
pp. 393-398 ◽  
Author(s):  
Payal Raina ◽  
Sudha Singh ◽  
Rajanigandha Tudu ◽  
Rashmi Singh ◽  
Anup Kumar

AbstractAim:The aim of this study was to compare volumetric modulated arc therapy (VMAT) with dynamic intensity-modulated radiation therapy (dIMRT) and step-and-shoot IMRT (ssIMRT) for different treatment sites.Materials and methods:Twelve patients were selected for the planning comparison study. This included three head and neck, three brain, three rectal and three cervical cancer patients. Total dose of 50 Gy was given for all the plans. Plans were done for Elekta synergy with Monaco treatment planning system. All plans were generated with 6 MV photons beam. Plan evaluation was based on the ability to meet the dose volume histogram, dose homogeneity index, conformity index and radiation delivery time, and monitor unit needs to deliver the prescribed dose.Results:The VMAT and dIMRT plans achieved the better conformity (CI98% = 0·965 ± 0·023) and (CI98% = 0·939 ± 0·01), respectively, while ssIMRT plans were slightly inferior (CI98% = 0·901 ± 0·038). The inhomogeneity in the planning target volume (PTV) was highest with ssIMRT with HI equal to 0·097 ± 0·015 when compared to VMAT with HI equal to 0·092 ± 0·0369 and 0·095 ± 0·023 with dIMRT. The integral dose is found to be inferior with VMAT 105·31 ± 53·6 (Gy L) when compared with dIMRT 110·75 ± 52·9 (Gy L) and ssIMRT 115 38 ± 55·1(Gy L). All the techniques respected the planning objective for all organs at risk. The delivery time per fraction for VMAT was much lower than dIMRT and ssIMRT.Findings:Our results indicate that dIMRT and VMAT provide better sparing of normal tissue, homogeneity and conformity than ssIMRT with reduced treatment delivery time.


2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Guillaume Vogin ◽  
Liza Hettal ◽  
Clarisse Bartau ◽  
Juliette Thariat ◽  
Marie-Virginie Claeys ◽  
...  

Abstract Background Segmentation is a crucial step in treatment planning that directly impacts dose distribution and optimization. The aim of this study was to evaluate the inter-individual variability of common cranial organs at risk (OAR) delineation in neurooncology practice. Methods Anonymized simulation contrast-enhanced CT and MR scans of one patient with a solitary brain metastasis was used for delineation and analysis. Expert professionals from 16 radiotherapy centers involved in brain structures delineation were asked to segment 9 OAR on their own treatment planning system. As reference, two experts in neurooncology, produced a unique consensual contour set according to guidelines. Overlap ratio, Kappa index (KI), volumetric ratio, Commonly Contoured Volume, Supplementary Contoured Volume were evaluated using Artiview™ v 2.8.2—according to occupation, seniority and level of expertise of all participants. Results For the most frequently delineated and largest OAR, the mean KI are often good (0.8 for the parotid and the brainstem); however, for the smaller OAR, KI degrade (0.3 for the optic chiasm, 0.5% for the cochlea), with a significant discrimination (p < 0.01). The radiation oncologists, members of Association des Neuro-Oncologue d’Expression Française society performed better in all indicators compared to non-members (p < 0.01). Our exercise was effective in separating the different participating centers with 3 of the reported indicators (p < 0.01). Conclusion Our study illustrates the heterogeneity in normal structures contouring between professionals. We emphasize the need for cerebral OAR delineation harmonization—that is a major determinant of therapeutic ratio and clinical trials evaluation.


2017 ◽  
Vol 8 (1) ◽  
pp. 29-34
Author(s):  
Nursama Heru Apriantoro ◽  
Bambang Sutrisno Wibowo ◽  
Muhammad Irsal ◽  
Prima Chintya Delsi Kasih

This study aims to analyze the difference in results between TPS 3D-CRT radiotherapy irradiation technique and IMRT radiotherapy irradiation technique in nasopharyngeal cancer cases based on the doses received by the target volume and organs at risk and results of isodosis curve which include the value of the index conformity and homogeneity index value. Type of this research is quantitative experimental method. As for the population was taken in 10 patients consisting of 5 male and 5 female patients with nasopharyngeal cancer who received radiation therapy with 3D-CRT irradiation technique and IMRT radiation technique. Meaningfully, the results shows that are no difference in the dose received by the target volume, the dose received by organs at risk, and the curve isodose on these two techniques, including index values of conformity and homogeneity index. In conclusion, IMRT radiotherapy irradiation technique for nasopharyngeal cancer is more prioritized than 3DCRT radiotherapy irradiation technique, as the radiotherapy principle can be achieved by using IMRT radiotherapy irradiation technique.


Author(s):  
Khamis Amour ◽  
Dr. Khamza Maunda ◽  
Dr. Mohamed Mazunga ◽  
Dr. Peane Maleka ◽  
Professor Peter Msaki

Although External Beam Radiation Therapy (EBRT) is essential tool for the radiation therapy of cervical cancer; only one cancer institute in Tanzania performs 3-Dimensional Conformal Radiation Therapy (3DCRT) Computed Tomography (CT)-based planning. To identify benefits and advantages of 3D-CRT over 2D- conventional radiation therapy (2D-CRT), dosimetric parameters for tumor targets and organs at risk (OARs) were compared between these modalities for 23 cervical cancer patients. 11 cervical cancer patients were CT scanned after proper positioning and immobilization and transferred to Eclipse Treatment Planning System (TPS) for dose planning. The remaining 12 curative intent patients were planned using 2D-CRT system and treatment times were calculated for each patient. From the CT based planning, the minimum dose (D min), maximum dose (D max) and mean dose (D mean) to Planning Target Volume (PTV) and organs at risk (OAR), were compared for each plan. On average, the optimized maximum doses for bladder, rectum, femoral heads, PTV and Gross Tumor Volume (GTV) were 46.56 Gy, 42.65 Gy, 28.76 Gy, 48.56 Gy and 48.53 Gy. For 2D-concentional planning, the dose rate was 75.75 cGy/min and the average treatment time was 1.6075 minutes. This study confirms that 3D CT-based planning is a good choice in the treatment protocol for carcinoma cervix as it delivered a highly homogeneous and conformal plan with superior dose coverage to PTV and better OARs sparing.


2018 ◽  
Vol 18 (02) ◽  
pp. 210-214
Author(s):  
R. P. Srivastava ◽  
C. De Wagter

AbstractPurposeIn advanced radiotherapy techniques such as intensity-modulated radiation therapy (IMRT), the quality assurance (QA) process is essential. The aim of the study was to assure the treatment planning dose delivered during delivery of complex treatment plans. The QA standard is to perform patient-specific comparisons between planned doses and doses measured in a phantom.Materials and methodThe Delta 4 phantom (Scandidos, Uppsala, Sweden) has been used in this study. This device consists of diode matrices in two orthogonal planes inserted in a cylindrical acrylic phantom. Each diode is sampled per beam pulse so that the dose distribution can be evaluated on segment-by-segment, beam-by-beam, or as a composite plan from a single set of measurements. Ninety-five simple and complex radiotherapy treatment plans for different pathologies, planned using a treatment planning system (TPS) were delivered to the QA device. The planned and measured dose distributions were then compared and analysed. The gamma index was determined for different pathologies.ResultsThe evaluation was performed in terms of dose deviation, distance to agreement and gamma index passing rate. The measurements were in excellent agreement between with the calculated dose of the TPS and the QA device. Overall, good agreement was observed between measured and calculated doses in most cases with gamma values above 1 in &gt;95% of measured points. Plan results for each test met the recommended dose goals.ConclusionThe delivery of IMRT and volumetric-modulated arc therapy (VMAT) plans was verified to correspond well with calculated dose distributions for different pathologies. We found the Delta 4 device is accurate and reproducible. Although Delta4 appears to be a straightforward device for measuring dose and allows measure in real-time dosimetry QA, it is a complex device and careful quality control is required before its use.


Author(s):  
Oleg N. Vassiliev ◽  
Christine B. Peterson ◽  
Joe Y. Chang ◽  
Radhe Mohan

Abstract Aim: The aim of this study was to investigate the extent to which lung stereotactic body radiotherapy (SBRT) treatment plans can be improved by replacing conventional flattening filter (FF) beams with flattening filter-free (FFF) beams. Materials and methods: We selected 15 patients who had received SBRT with conventional 6-MV photon beams for early-stage lung cancer. We imported the patients’ treatment plans into the Eclipse 13·6 treatment planning system, in which we configured the AAA dose calculation model using representative beam data for a TrueBeam accelerator operated in 6-MV FFF mode. We then created new treatment plans by replacing the conventional FF beams in the original plans with FFF beams. Results: The FFF plans had better target coverage than the original FF plans did. For the planning target volume, FFF plans significantly improved the D98, D95, D90, homogeneity index and uncomplicated tumour control probability. In most cases, the doses to organs at risk were lower in FFF plans. FFF plans significantly reduced the mean lung dose, V10, V20, V30, and normal tissue complication probability for the total lung and improved the dosimetric indices for the ipsilateral lung. For most patients, FFF beams achieved lower maximum doses to the oesophagus, heart and the spinal cord, and a lower chest wall V30. Conclusions: Compared with FF beams, FFF beams achieved lower doses to organs at risk, especially the lung, without compromising tumour coverage; in fact, FFF beams improved coverage in most cases. Thus, replacing FF beams with FFF beams can achieve a better therapeutic ratio.


2020 ◽  
Author(s):  
Wufei Cao ◽  
Yongdong Zhuang ◽  
Lixin Chen ◽  
Xiaowei Liu

Abstract Purpose: In this study, we employed a gated recurrent unit (GRU)-based recurrent neural network (RNN) using dosimetric information induced by individual beam to predict the dose-volume histogram (DVH) and investigated the feasibility and usefulness of this method in biologically related models for nasopharyngeal carcinomas (NPC) treatment planning.Methods and Materials: One hundred patients with NPC undergoing volumetric modulated arc therapy (VMAT) between 2018 and 2019 were randomly selected for this study. All the VMAT plans were created using the Monaco treatment planning system (Elekta, Sweden) and clinically approved: >98% of PGTVnx received the prescribed doses of 70 Gy, >98% of PGTVnd received the prescribed doses of 66 Gy and >98% of PCTV received 60 Gy. Of these, the data from 80 patients were used to train the GRU-RNN, and the data from the other 20 patients were used for testing. For each NPC patient, the DVHs of different organs at risk were predicted by a trained GRU-based RNN using the information given by individual conformal beams. Based on the predicted DVHs, the equivalent uniform doses (EUD) were calculated and applied as dose constraints during treatment planning optimization. The regenerated VMAT experimental plans (EPs) were evaluated by comparing them with the clinical plans (CPs).Results: For the 20 test patients, the regenerated EPs guided by the GRU-RNN predictive model achieved good consistency relative to the CPs. The EPs showed better consistency in PTV dose distribution and better dose sparing for many organs at risk, and significant differences were found in the maximum/mean doses to the brainstem, brainstem PRV, spinal cord, lenses, temporal lobes, parotid glands and larynx with P-values <0.05. On average, compared with the CPs, the maximum/mean doses to these OARs were altered by -3.44 Gy, -1.94 Gy, -1.88 Gy, 0.44 Gy, 1.98 Gy, -1.82 Gy and 2.27 Gy, respectively. In addition, significant differences were also found in brainstem and spinal cord for the dose received by 1cc volume with 4.11 and 1.67 Gy dose reduction in EPs on average.Conclusion: The GRU-RNN-based DVH prediction method was capable of accurate DVH prediction. The regenerated plans guided by the predicted EUDs were not inferior to the manual plans, had better consistency in PTVs and better dose sparing in critical OARs, indicating the usefulness and effectiveness of biologically related model in knowledge-based planning.


Sign in / Sign up

Export Citation Format

Share Document